<DOC>
	<DOC>NCT01658618</DOC>
	<brief_summary>This observations safety study is intended for subject who participated in the 802-247-09-029 study with the investigational product HP802-247 for venous leg ulcers and received at least one application of HP802-247 or Vehicle (an inactive substance). This study is being done for the following purposes: 1. to identify new adverse events, 2. to examine ongoing adverse events not resolved in subjects who participated in the 802-247-09-029 trial, 3. to record wound status, and 4. to determine if there are differences in Health Related Quality of Life (HRQoL) associated with the treatment assignment from the 802-247-09-029 Trial. Investigational means that HP802-247 has not been approved by the U.S. Food and Drug Administration (FDA).</brief_summary>
	<brief_title>Safety Study Providing 12 Months Follow-up From First Exposure to HP802-247 in Subjects With Venous Leg Ulcer</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>Provide informed consent document Subject was randomized in 80224709029 and received at least one application of a test article. Subject has ended their participation in 80224709029 by virtue of completing the study, or by dropping out prior to completion. Subjects who refuse to provide written informed consent will be excluded from this trial.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Venous leg ulcer</keyword>
	<keyword>ulcer</keyword>
	<keyword>venous stasis</keyword>
	<keyword>compression</keyword>
	<keyword>venous</keyword>
	<keyword>venous stasis ulcer</keyword>
	<keyword>vlu</keyword>
	<keyword>hp802-247-09-029</keyword>
</DOC>